Compared to Estimates, Sarepta Therapeutics (SRPT) Q1 Earnings: A Look at Key Metrics

For the quarter ended March 2025, Sarepta Therapeutics (SRPT) reported revenue of $744.86 million, up 80.2% over the same period last year. EPS came in at -$ 3.42, compared to $0.73 in the year-ago quarter. The reported revenue represents a surprise of +6.68% over the Zacks Consensus Estimate of$ 698.2 million. With the consensus EPS estimate being $0.35, the EPS surprise was -1077.14%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to ...